Neil Belloff
General Counsel at ACORDA THERAPEUTICS, INC.
Net worth: - $ as of 2024-04-29
Neil Belloff active positions
| Companies | Position | Start | End |
|---|---|---|---|
| ACORDA THERAPEUTICS, INC. | General Counsel | 2021-11-07 | - |
| Corporate Secretary | 2022-05-31 | - |
Career history of Neil Belloff
Former positions of Neil Belloff
| Companies | Position | Start | End |
|---|---|---|---|
| ELOXX PHARMACEUTICALS, INC. | Chief Operating Officer | 2020-01-31 | 2021-08-24 |
| General Counsel | 2018-06-17 | 2021-08-24 | |
| Corporate Secretary | 2018-06-17 | 2021-08-24 | |
| CELGENE | Corporate Officer/Principal | 2010-12-31 | - |
| DEUTSCHE TELEKOM AG | Corporate Officer/Principal | - | - |
Training of Neil Belloff
| Quinnipiac University School of Law | Graduate Degree |
| New York University | Graduate Degree |
| Queens College | Undergraduate Degree |
Statistics
International
| United States | 7 |
| Germany | 2 |
Operational
| General Counsel | 2 |
| Corporate Secretary | 2 |
| Graduate Degree | 2 |
Sectoral
| Health Technology | 4 |
| Consumer Services | 4 |
| Communications | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 3 |
|---|---|
| ELOXX PHARMACEUTICALS, INC. | Health Technology |
| DEUTSCHE TELEKOM AG | Communications |
| ACORDA THERAPEUTICS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
- Stock Market
- Insiders
- Neil Belloff
- Experience
